Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency . Clinics, [S. l.], v. 66, n. 8, p. 1361–1366, 2011. DOI: 10.1590/S1807-59322011000800009. Disponível em: https://www.revistas.usp.br/clinics/article/view/19259.. Acesso em: 15 jun. 2024.